Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Aug;85(3):398–404. doi: 10.1054/bjoc.2001.1926

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears

G D Zielinski 1, P J F Snijders 1, L Rozendaal 1, F J Voorhorst 2, H C van der Linden 1, A P Runsink 4, F A de Schipper 3, C J L M Meijer 1
PMCID: PMC2364067  PMID: 11487272

Abstract

In a retrospective case–control study, we investigated high-risk HPV DNA presence by general primer GP5+/6+ PCR in the last normal cervical smear in the patient archives (i.e. baseline smear) of 57 women who later developed cervical cancer. Also, normal cervical smears of 114 age-matched control women were analysed. High-risk HPV DNA was detected in 37 of the 57 (65%) baseline smears of the case women, and 7 (6%) of 114 smears of the control women (OR 28, 95% Cl 11–72). The HPV positive subsequent smears and cervical cancer biopsies of the case women contained the same HPV type as was detected in the baseline smear. After cytological revision, the baseline smears of 48 case women (84%) were reclassified as abnormal, 33 (69%) of which scored high-risk HPV DNA positive. Ultimately, an undisputable normal baseline smear was found in only 10 case women. In 7 (70%) of them this smear was HPV positive, whereas only 7 (7%) of 104 revised, undisputable normal smears of control women were high-risk HPV positive (OR 32, 95% Cl 6.8–153). The results showed that (1) high-risk HPV presence precedes abnormal cytology in women who develop cervical cancer, and (2) high-risk HPV testing signals false-negative smears of women at risk of cervical cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: HPV, cervical cancer, archival smears: case–control study, normal cytology, false negative cytology

Full Text

The Full Text of this article is available as a PDF (87.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  2. Cuzick J., Terry G., Ho L., Monaghan J., Lopes A., Clarkson P., Duncan I. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer. 2000 Apr;82(7):1348–1352. doi: 10.1054/bjoc.1999.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ho G. Y., Bierman R., Beardsley L., Chang C. J., Burk R. D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998 Feb 12;338(7):423–428. doi: 10.1056/NEJM199802123380703. [DOI] [PubMed] [Google Scholar]
  4. Hopman E. H., Rozendaal L., Voorhorst F. J., Walboomers J. M., Kenemans P., Helmerhorst T. J. High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. BJOG. 2000 May;107(5):600–604. doi: 10.1111/j.1471-0528.2000.tb13299.x. [DOI] [PubMed] [Google Scholar]
  5. Jacobs M. V., Snijders P. J., van den Brule A. J., Helmerhorst T. J., Meijer C. J., Walboomers J. M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997 Mar;35(3):791–795. doi: 10.1128/jcm.35.3.791-795.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jacobs M. V., Zielinski D., Meijer C. J., Pol R. P., Voorhorst F. J., de Schipper F. A., Runsink A. P., Snijders P. J., Walboomers J. M. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer. 2000 Apr;82(8):1421–1426. doi: 10.1054/bjoc.1999.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Josefsson A. M., Magnusson P. K., Ylitalo N., Sørensen P., Qwarforth-Tubbin P., Andersen P. K., Melbye M., Adami H. O., Gyllensten U. B. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000 Jun 24;355(9222):2189–2193. doi: 10.1016/S0140-6736(00)02401-6. [DOI] [PubMed] [Google Scholar]
  8. Koutsky L. A., Holmes K. K., Critchlow C. W., Stevens C. E., Paavonen J., Beckmann A. M., DeRouen T. A., Galloway D. A., Vernon D., Kiviat N. B. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992 Oct 29;327(18):1272–1278. doi: 10.1056/NEJM199210293271804. [DOI] [PubMed] [Google Scholar]
  9. Melkert P. W., Hopman E., van den Brule A. J., Risse E. K., van Diest P. J., Bleker O. P., Helmerhorst T., Schipper M. E., Meijer C. J., Walboomers J. M. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer. 1993 Apr 1;53(6):919–923. doi: 10.1002/ijc.2910530609. [DOI] [PubMed] [Google Scholar]
  10. Nobbenhuis M. A., Walboomers J. M., Helmerhorst T. J., Rozendaal L., Remmink A. J., Risse E. K., van der Linden H. C., Voorhorst F. J., Kenemans P., Meijer C. J. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999 Jul 3;354(9172):20–25. doi: 10.1016/S0140-6736(98)12490-X. [DOI] [PubMed] [Google Scholar]
  11. Robertson J. H., Woodend B. Negative cytology preceding cervical cancer: causes and prevention. J Clin Pathol. 1993 Aug;46(8):700–702. doi: 10.1136/jcp.46.8.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rozendaal L., Walboomers J. M., van der Linden J. C., Voorhorst F. J., Kenemans P., Helmerhorst T. J., van Ballegooijen M., Meijer C. J. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996 Dec 11;68(6):766–769. doi: 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  13. Vooijs G. P. De advisering bij afwijkende bevindingen van cytologisch onderzoek van de cervix uteri. Ned Tijdschr Geneeskd. 1987 Sep 19;131(38):1662–1663. [PubMed] [Google Scholar]
  14. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  15. Walboomers J. M., de Roda Husman A. M., Snijders P. J., Stel H. V., Risse E. K., Helmerhorst T. J., Voorhorst F. J., Meijer C. J. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol. 1995 Aug;48(8):728–732. doi: 10.1136/jcp.48.8.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wallin K. L., Wiklund F., Angström T., Bergman F., Stendahl U., Wadell G., Hallmans G., Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med. 1999 Nov 25;341(22):1633–1638. doi: 10.1056/NEJM199911253412201. [DOI] [PubMed] [Google Scholar]
  17. Ylitalo N., Josefsson A., Melbye M., Sörensen P., Frisch M., Andersen P. K., Sparén P., Gustafsson M., Magnusson P., Pontén J. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res. 2000 Nov 1;60(21):6027–6032. [PubMed] [Google Scholar]
  18. Ylitalo N., Sørensen P., Josefsson A. M., Magnusson P. K., Andersen P. K., Pontén J., Adami H. O., Gyllensten U. B., Melbye M. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 2000 Jun 24;355(9222):2194–2198. doi: 10.1016/S0140-6736(00)02402-8. [DOI] [PubMed] [Google Scholar]
  19. de Roda Husman A. M., Walboomers J. M., Meijer C. J., Risse E. K., Schipper M. E., Helmerhorst T. M., Bleker O. P., Delius H., van den Brule A. J., Snijders P. J. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer. 1994 Mar 15;56(6):802–806. doi: 10.1002/ijc.2910560607. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES